期刊文献+

用三联法根除幽门螺杆菌失败后的补救方案 被引量:6

Rescue regimen after Helicobacter pylori eradication failure with triple therapy
下载PDF
导出
摘要 目的探讨三联疗法(质子泵抑制剂+阿莫西林+克拉霉素)根除幽门螺杆菌(HP)治疗失败后的补救方案。方法将95名HP感染且三联疗法根除HP治疗失败的患者,随机分为试验组与对照组,并分别用新三联法(质子泵抑制剂+阿莫西林+左氧氟沙星)与四联法(质子泵抑制剂+铋剂+四环素+甲硝唑)比较,在治疗结束时和结束后4周,检测HP,并评价耐受性。结果在HP根除率和耐受性,试验组优于对照组。结论以左氧氟沙星为基础的新三联方案是有效的补救方案,优于四联方案。 Objective To investigate the rescue regimens after failed of Helicobacter pylori (HP)eradication with standard triple therapy. Methotis Ninety-five patients who infected HP with triple therapy (PPI + amoxicillin + clarithromycin)failed were random devided into trial group ( PPI + levofloxacin + amoxicillin) and control group ( quadruple therapy) ,then the rate of HP eradication was evaluated, the adverce reaction was evaluated after the end of treatment . Results Trial group was better than control group in rate of HP eradication, trial group was less than control group in adverse reaction. Conclusion After HP eradication failure, levofloxacin-based rescue regimen is more effective and tolerated better than the generally recommended quadruple therapy.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2008年第4期361-363,共3页 The Chinese Journal of Clinical Pharmacology
关键词 幽门螺杆菌 根除 左氧氟沙星 补救方案 Helicobacter pylori eradication levofloxacin rescue regimen
  • 相关文献

参考文献8

  • 1Gisbert JP, Pajares JM. Helicobacter pylori rescue therapy after failure of two eradication treatments[ J]. Helicobacter,2005 ; 10:363 - 372.
  • 2Nista EC, Candelli M, Cremonini F. Levofloxacin - based triple thempy vs. Quadruple therapy in second - line Helicobacter pylori threatment [J]. Aliment Pharmacol Thre, 2003 ;18:627 -633.
  • 3Miehlke S, Madisch A, Bastlein E, et al. Oneweek triple therapy with esomeprazole, levofloxacin and amoxicillin is effective for eradication of Helicobacter pylori sensitive or resistant to metronidazole and/or clarithromycin [ J ]. Helicobacter,2003 ; 8:464 .
  • 4Uemura N, Okamoto S, Yamamoto S. et al. Helicobacter pylori infection and the development of gastric cancer[ J]. NEngl J Med,2001 ;345: 784 - 789.
  • 5Sanchez JE, Saenz NG, Rincon MR ,et al. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones [ J ]. J Antimicrob Chemother, 2000 ;46 : 283 - 285.
  • 6Gatta L, Zullo A, Perna F, et al. A 10 - day levofloxacin - based triple therapy in patients who have failed two eradication courses[ J ]. Aliment Pharmacol Ther,2005 ;22:45 -49.
  • 7邹军,杨昭徐,覃卓明.左旋氧氟沙星抗幽门螺杆菌的实验室评价和临床研究[J].中华医学杂志,2003,83(20):1778-1781. 被引量:87
  • 8Tanaka M, Isogai E, Isogai H, et al. Synergic effect of guinolone antibacterial agents and proton pump jihibitors on Helicobacter pylori [ J ]. J Antimicrob Chemother, 2002 ;49 : 1039 - 1040.

二级参考文献16

  • 1黄跃,许鲁宁.环丙沙星一周疗法根除幽门螺杆菌[J].中国新药杂志,1994,3(2):34-36. 被引量:10
  • 2Van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Theatment of Helicobacter pylori infection: a review of the world literature. Helicobacter, 1996,1:6-19.
  • 3Georgopoulos SD, Ladas SD, Karatapanis S, et al. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci,2000 ,45:63-67.
  • 4Piccolomini R, Bonaventura G, Catamo G, et al. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol,1997,35:1842-1844.
  • 5Pfaller MA, Barry AL, Fuchs PC, et al. Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests. J Clin Microbiol,1993, 31:1924-1926.
  • 6Sharma VK, Vasudeva R, Howden CW. A national survey of gastroenterologists' current opinions and practices related to Hp. Am J Gastroenterol,1998,93:1647-1657.
  • 7Franzin L, Pennazio M, Cabodi D, et al. Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol, 2000,40:96-100.
  • 8Ducons JA, Santolaria S, Guirao R, et al. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a porospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther, 1999,13:775-780.
  • 9Yakoob J, Fan XG, Hu GL, et al. Antibiotic susceptibility of Helicobacter pylori in the chinese population. J Gastroenterol Hepatol, 2001,16:981-985.
  • 10Maria PD, Gioacchino L, giuseppe R, et al. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: A meta-analytical approach. Dig Dis Sic, 2000,45:68-76.

共引文献86

同被引文献43

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部